胸肌前双阶段假体乳房重建:脱细胞真皮基质用与不用有无差异
单术者回顾性研究比较胸肌前双阶段假体乳房重建中使用与不使用脱细胞真皮基质(ADM)的结局,共40例(ADM组19例,非ADM组21例)。两组并发症少且美学评分无显著差异,选择性使用ADM可节约成本。
要点
- 在血运良好、厚度均匀的皮瓣患者中,胸肌前双阶段假体乳房重建可不用ADM。
- ADM组与非ADM组的BREAST-Q和Aesthetic Item Scale评分无显著差异。
- 选择性使用ADM可减少患者和医疗系统的经济负担。
核心结论
- 在充分选择患者的前提下,胸肌前双阶段假体乳房重建不一定需要ADM即可获得良好美学效果。
- 选择性使用ADM可减轻患者和医疗系统的经济负担。
研究设计与样本
- 单术者回顾性综述,纳入两个时期内在保留乳头乳房切除术后接受分期胸肌前假体乳房重建的患者。
- 共40例患者,ADM组19例,非ADM组21例;分析人口学、手术数据和并发症,并做成本分析。
主要发现
- 非ADM组有1例(5%)血清肿和1例(5%)血肿,ADM组无此类并发症。
- ADM组与非ADM组的平均BREAST-Q评分分别为82.3与81.6(p=0.954)。
- ADM组与非ADM组的平均Aesthetic Item Scale评分分别为20.98与20.43(p=0.640)。
- 若所有假体乳房重建病例均不使用ADM,作者机构按Medicare报销估算1年直接成本节省:单侧为3,105,960美元,双侧为6,211,920美元。
临床怎么用
- 对乳房切除皮瓣血运良好且厚度均匀的患者,可考虑在胸肌前双阶段假体乳房重建中省略ADM。
- 结合美学评分与成本分析,选择性使用ADM而非常规使用。
局限性
- 单术者回顾性研究,样本量40例,证据等级为治疗性III级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prepectoral implant-based breast reconstruction has gained popularity because of advantages over the subpectoral technique. Acellular dermal matrix use with implant-based breast reconstruction has become common because of its perceived superior aesthetic outcome. Matrices are expensive, however, and recent evidence has pointed to several potential complications. This article reports a series of prepectoral implant-based breast reconstructions with and without acellular dermal matrix and compared their outcomes. METHODS: This is a single-surgeon retrospective review of patients who underwent staged prepectoral implant-based breast reconstruction following nipple-sparing mastectomy over two periods. Patients with well-perfused mastectomy skin flaps with a homogeneous thickness underwent reconstruction with acellular dermal matrix initially. On evolution of the practice, it was not used. Patient demographics, operative data, and complications were analyzed. Aesthetic outcome was measured by the BREAST-Q survey and the Aesthetic Item Scale. A cost analysis was also performed. RESULTS: Forty patients were included (acellular dermal matrix group, n = 19; non-acellular dermal matrix group, n = 21). The nonmatrix group had one case (5 percent) of seroma and one case (5 percent) with hematoma; there were none in the acellular dermal matrix group. Average BREAST-Q and Aesthetic Item Scale scores were 82.3 versus 81.6 (p = 0.954) and 20.98 versus 20.43 (p = 0.640) for the matrix and nonmatrix groups, respectively. The direct cost savings for the authors' institution over 1 year if matrix was not used in all cases of implant-based breast reconstruction would be estimated at $3,105,960 to $6,211,920 for unilateral and bilateral cases, respectively, for Medicare reimbursement. CONCLUSIONS: With adequate patient selection, acellular dermal matrix is not always required during two-stage prepectoral implant-based breast reconstruction for good aesthetic outcomes. The economic burden on patients and the health care system could be lessened with selective matrix use. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
引用
- Manrique OJ, Huang TC, Martinez-Jorge J, et al. Prepectoral Two-Stage Implant-Based Breast Reconstruction with and without Acellular Dermal Matrix: Do We See a Difference? Plast Reconstr Surg. 2020. PMID: 31985613. doi:10.1097/PRS.0000000000006442
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。